The increased expression of Bcl-2, and more precisely the unfavorable ratio of the pro-apoptotic Bax protein to the anti-apoptotic Bcl-2 protein, determines the high resistance of this tumor to chemotherapy. The gene discussed is BCL2; the disease is neoplasm.